AB0456 HYDROXYCHLOROQUINE MIGHT REDUCE MORTALITY IN PATIENTS WITH SYSTEMIC SCLEROSIS
AB0456 HYDROXYCHLOROQUINE MIGHT REDUCE MORTALITY IN PATIENTS WITH SYSTEMIC SCLEROSIS
About this item
Full title
Author / Creator
Ozmen, M. , Otman Akat, E. , Gucenmez, S. , Kabadayi, G. , Durak Ediboglu, E. , Alp, G. , Cinakli, H. , Erpek, E. , Kurut Aysin, İ. , Bayindir, O. , Solmaz, D. and Akar, S.
Publisher
Elsevier B.V
Journal title
Language
English
Formats
Publication information
Publisher
Elsevier B.V
More information
Scope and Contents
Contents
Systemic sclerosis (SSc) is a devastating disease that has a profound impact on life expectancy, reflected by a standardised mortality ratio of 3,5. There is still limited data regarding the predictive factors for mortality in patients with SSc. Determining those factors could guide in disease management and follow up.1
We aimed to identify the...
Alternative Titles
Full title
AB0456 HYDROXYCHLOROQUINE MIGHT REDUCE MORTALITY IN PATIENTS WITH SYSTEMIC SCLEROSIS
Authors, Artists and Contributors
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_crossref_primary_10_1136_annrheumdis_2021_eular_3685
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_crossref_primary_10_1136_annrheumdis_2021_eular_3685
Other Identifiers
ISSN
0003-4967
DOI
10.1136/annrheumdis-2021-eular.3685
